Literature DB >> 2705196

Assessment of thrombogenic potential of liposomes.

G Zbinden1, H Wunderli-Allenspach, L Grimm.   

Abstract

The effects of liposomes with positive, neutral and negative surface charges on platelets and the plasmatic coagulation system were investigated in several in vitro and in vivo models. Negatively charged liposomes stimulated the plasmatic contact activating system as demonstrated by significant acceleration of whole blood clotting time measured in containers with nonwettable (siliconized) surface. The same liposomes induced reversible aggregates of human platelets in vitro and circulating reversible platelet aggregates after intravenous infusion in guinea pigs. Liposomes with positive and neutral surface charges had no effect on plasmatic coagulation and platelets. The biological mechanisms and the toxicological relevance of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2705196     DOI: 10.1016/0300-483x(89)90063-2

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  8 in total

Review 1.  Immunological risk of injectable drug delivery systems.

Authors:  Wim Jiskoot; Rianne M F van Schie; Myrra G Carstens; Huub Schellekens
Journal:  Pharm Res       Date:  2009-02-27       Impact factor: 4.200

2.  Hemocompatibility assessment of two siRNA nanocarrier formulations.

Authors:  Afrouz Yousefi; Marianne Lauwers; Reka Nemes; Thijs van Holten; Negar Babae; Mark Roest; Gert Storm; Raymond Schiffelers; Enrico Mastrobattista
Journal:  Pharm Res       Date:  2014-05-20       Impact factor: 4.200

3.  Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles.

Authors:  J M Koziara; J J Oh; W S Akers; S P Ferraris; R J Mumper
Journal:  Pharm Res       Date:  2005-08-26       Impact factor: 4.200

4.  Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro.

Authors:  Marina A Dobrovolskaia; Anil K Patri; Jan Simak; Jennifer B Hall; Jana Semberova; Silvia H De Paoli Lacerda; Scott E McNeil
Journal:  Mol Pharm       Date:  2011-11-10       Impact factor: 4.939

Review 5.  Nanoparticles and the blood coagulation system. Part II: safety concerns.

Authors:  Anna N Ilinskaya; Marina A Dobrovolskaia
Journal:  Nanomedicine (Lond)       Date:  2013-06       Impact factor: 5.307

6.  Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel.

Authors:  Nijaporn Yanasarn; Brian R Sloat; Zhengrong Cui
Journal:  Int J Pharm       Date:  2009-06-11       Impact factor: 5.875

Review 7.  Action of Nanoparticles on Platelet Activation and Plasmatic Coagulation.

Authors:  Eleonore Fröhlich
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

Review 8.  Immunological and Toxicological Considerations for the Design of Liposomes.

Authors:  Collin T Inglut; Aaron J Sorrin; Thilinie Kuruppu; Shruti Vig; Julia Cicalo; Haroon Ahmad; Huang-Chiao Huang
Journal:  Nanomaterials (Basel)       Date:  2020-01-22       Impact factor: 5.076

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.